Drug‐eluting stents for the treatment of in‐stent restenosis – ‘real world’ double centre experience in consecutive patients

References

• Lowe H. C., Osterle S. N., Khachigian L. M. Coronary in‐stent restenosis: current status and future strategies. J Am Coll Cardiol 2002; 39: 183–93
   PubMed Web of Science ®Google Scholar
• Babapule M. N., Eisenberg M. J. Coated stents for the prevention of restenosis: Part I. Circulation 2002; 106: 2734–40
   PubMed Web of Science ®Google Scholar
• Babapule M. N., Eisenberg M. J. Coated stents for the prevention of restenosis: Part II. Circulation 2002; 106: 2859–66
   PubMed Web of Science ®Google Scholar
• Mintz G. S., Popma J. J., Pichard A. D., et al. Arterial remodeling after coronary angioplasty: A serial intravascular ultrasound study. Circulation 1996; 94: 398–400
   PubMed Web of Science ®Google Scholar
• Grube E., Silber S., Hauptmann K. E., et al. TAXUS I: six‐ and twelve‐month results from a randomized, double‐blind trial on a slow‐release paclitaxel‐eluting stent for de novo coronary lesions. Circulation 2003; 107: 38–42
   PubMed Web of Science ®Google Scholar
• Colombo A., Drzewieki J., Banning A., et al. TAXUS II Study Group. Randomised study to assess the effectiveness of slow‐ and moderate‐release polymer‐based paclitaxel‐eluting stents for coronary artery lesions. Circulation 2003; 108: 788–94
   PubMed Web of Science ®Google Scholar
• Morice M. C., Serruys P. W., Sousa J. E., et al. RAVEL Study Group. Randomized Study with the sirolimus‐coated Bx Velocity Balloon‐Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. N Engl J Med 2002; 346: 1773–80
   PubMed Web of Science ®Google Scholar
• Mose J. W., Leon M. B., Popma J. J., et al. SIRIUS Investigators. Sirolimus‐eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315–23
   PubMed Web of Science ®Google Scholar
• Bauters C., Banos J. ‐L., Belle E., et al. Six month angiographic outcome after successful repeat PCI for in‐stent restenosis. Circulation 1998; 97: 318–21
   PubMed Web of Science ®Google Scholar
• Chua D. C., Almeda F. Q., Senter S., et al. Predictors of late cardiac events following treatment with SR‐90 beta‐irradiation for instent restenosis. Cardivasc Radiat Med 2003; 4: 7–11
   PubMedGoogle Scholar
• Degertekin M., Lemos P. A., Lee C. H., et al. Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in‐stent restenosis lesions. Eur Heart J 2004; 25: 32–8
   PubMed Web of Science ®Google Scholar
• Lemos P. A., Lee C. H., Sianos G., et al. Sirolimus‐Eluting Stent Implantation in the “Real‐World”: Initial Results of the RESEARCH Registry. Am J Cardiol 2002; 90: 6H
   Web of Science ®Google Scholar
• Tanabe K., Serruys P. W., Grube E., et al. TAXUS III Trial: in‐stent restenosis treated with stent‐based delivery of paclitaxel incorporated in a slow‐release polymer formulation. Circulation 2003; 107: 559–64
   PubMed Web of Science ®Google Scholar
• Tanabe K., Serruys P. W., Grube E., et al. TAXUS III Trial: in‐stent restenosis treated with stent‐based delivery of paclitaxel incorporated in a slow‐release polymer formulation. Circulation 2003; 107: 559–64
   PubMed Web of Science ®Google Scholar
• Sousa J. E., Costa M. A., Abizaid A., et al. Sirolimus‐eluting stent for the treatment of in‐stent restenosis quantitative coronary angiography and three‐dimensional intravascular ultrasound study. Circulation 2003; 107: 24–7
   PubMed Web of Science ®Google Scholar
• Degertekin M., Regar E., Tanabe K., et al. Sirolimus‐eluting stent for treatment of complex in‐stent restenosis: the first clinical experience. J Am Coll Cardiol 2003; 41: 184–9
   PubMed Web of Science ®Google Scholar
• Saia F., Lemos, Arampatzis C. A., et al. Routine sirolimus eluting stent implantation for unselected in‐stent restenosis:insights from the rapamycin eluting stent evaluated at Rotterdam cardiology hospital (RESEARCH) registry. Heart 2004; 90: 1183–8
   PubMed Web of Science ®Google Scholar
• Werner G. S., Emig U., Krack A., Schwarz G., Figulla H. R. Sirolimus‐eluting stents for the prevention of restenosis in a worst‐case scenario of diffuse and recurrent in‐stent restenosis. Cath Cardiovasc Interv 2004; 63: 259–64
   PubMed Web of Science ®Google Scholar
• Saia F., Lemos P. A., Sianos G., et al. Effectiveness of sirolimus‐eluting stent implantation for recurrent in‐stent restenosis after brachtherapy. Am J Cardiol 2003; 92: 200–3
   PubMed Web of Science ®Google Scholar
• Mauri L., O'Malley A. J., Cutlip D. E., et al. Effects of stent length and lesion length on coronary restenosis. Am J Cardiol 2004; 93: 1340–6
   PubMed Web of Science ®Google Scholar
• Saia F., Lemos, Arampatzis C. A., et al. Routine sirolimus eluting stent implantation for unselected in‐stent restenosis:insights from the rapamycin eluting stent evaluated at Rotterdam cardiology hospital (RESEARCH) registry. Heart 2004; 90: 1183–8
   PubMed Web of Science ®Google Scholar
• Kastrati A., Mehilli J., von Beckerath N., et al. ISAR‐DESIRE study investigators. JAMA 2005; 293: 165–71
   PubMed Web of Science ®Google Scholar